You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Romiplostim for the treatment of chronic immune thrombocytopenia

  • Technology appraisal guidance
  • Reference number: TA221
  • Published:  27 April 2011
  • Last updated:  26 October 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

NICE recommends romiplostim for the treatment of rare blood disorder

2011/072 NICE recommends romiplostim for the treatment of rare blood disorder

2011/072 NICE recommends romiplostim for the treatment of rare blood disorder2011/072 NICE recommends romiplostim for the treatment of rare blood disorder
26 April 2011
(69.45 Kb 20 sec @ 28.8Kbps)
Adobe Acrobat reader required.

 Adobe Acrobat reader required.

Back to top